2022 annual financial data
Vertex Pharmaceuticals 2022 Operating margin
Vertex Pharmaceuticals 2022 operating margin with verified reported values.
Direct answer
Operating margin was 48.23%.
Operating income was 4,307,400,000 USD and net income was 3,322,000,000 USD.
Operating cash flow was 4,129,900,000 USD.
Verified data
- Revenue
- 8,930,700,000 USD
- Operating income
- 4,307,400,000 USD
- Net income
- 3,322,000,000 USD
- Operating cash flow
- 4,129,900,000 USD